Transoral laser surgery for pharyngeal and pharyngolaryngeal carcinomas

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 2, 2007, Pages 139-144

  Kutter, Jürg ^a   Lang, Florian ^a   Monnier, Philippe ^a   Pasche, Philippe ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION PNEUMONIA; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REHABILITATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARBON DIOXIDE LASER; COMORBIDITY; CONTROLLED STUDY; FEEDING APPARATUS; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HOSPITALIZATION; HUMAN; INVASIVE CARCINOMA; LARYNGOSCOPE; LARYNX CARCINOMA; LARYNX STENOSIS; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; NECK DISSECTION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PAIN ASSESSMENT; PHARYNX CARCINOMA; PHARYNX EXAMINATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TERTIARY HEALTH CARE; TRACHEOTOMY; TREATMENT REFUSAL; UNIVERSITY HOSPITAL;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; ENTERAL NUTRITION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LASER SURGERY; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; ORAL SURGICAL PROCEDURES; PHARYNGEAL NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TRACHEOTOMY;

EID: 33847115816     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.2.139     Document Type: Article

References (24)

1. Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M. Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results. Otolaryngol Head Neck Surg. 2001;124:561-569.
2. Pignon JP, Bourhis J, Domenge C, Designé L; MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet. 2000;355:949-955.
3. Kutter J, Ozsahin M, Monnier P, Stupp R. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma. Eur Arch Otorhinolaryngol. 2005;262:1-7.
4. Bron LP, Soldati D, Monod ML, et al. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2005;262:302-306.
5. Markou K, Nikolaou A, Nalbadian M, Petridis D, Nicolaidis V, Daniilidis I. How often is total laryngectomy necessary for the treatment of T1 failures after radiotherapy or cordotomy? Eur Arch Otorhinolaryngol. 2002;259:4-10.
6. Bron LP, Soldati D, Zouhair A, et al. Treatment of early stage squamous-cell carcinoma of the glottic larynx: endoscopic surgery or cricohyoidoepiglottopexy versus radiotherapy. Head Neck. 2001;23:823-829.
7. Delsupehe KG, Zink I, Lejaegere M, Bastian RW. Voice quality after narrow-margin laser cordectomy compared with laryngeal irradiation. Otolaryngol Head Neck Surg. 1999;121:528-533.
8. Zeitels SM. Phonomicrosurgical treatment of early glottic cancer and carcinoma in situ. Am J Surg. 1996;172:704-709.
9. Steiner W, Ambrosch P, Hess CF, Kron M. Organ preservation by transoral laser microsurgery in piriform sinus carcinoma. Otolaryngol Head Neck Surg. 2001;124:58-67.
10. Rudert HH, Höft S. Transoral carbon-dioxide laser resection of hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol. 2003;260:198-206.
11. Oeken J, Hänsch U, Thiel S, Bootz F. Swallowing function after endoscopic resection of supraglottic carcinoma with the carbon dioxide laser. Eur Arch Otorhinolaryngol. 2001;258:250-254.
12. Bernal-Sprekelsen M, Vilaseca-Gonzalez I, Blanch-Alejandro JL. Predective values for aspiration after endoscopic laser resections of malignant tumors of the hypopharynx and larynx. Head Neck. 2004;26:103-110.
13. Portugal LG, Wilson KM, Biddinger PW, Gluckman JL. The role of toluidine blue in assessing margin status after resection of squamous cell carcinomas of the upper aerodigestive tract. Arch Otolaryngol Head Neck Surg. 1996;122:517-519.
14. Ambrosch P, Brinck U, Fischer G, Steiner W. Special aspects of histopathologic diagnosis in laser microsurgery of cancers of the upper aerodigestive tract. Laryngorhinootologie. 1994;73:78-83.
15. Vilaseca-Gonzalez I, Bernal-Sprekelsen M, Blanch-Alejandro JL, Moragas-Lluis M. Complications in transoral CO2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck. 2003;25:382-388.
16. Vilaseca I, Blanch JL, Bernal-Sprekelsen M, Moragas M. CO2 laser surgery: a larynx preservation alternative for selected hypopharyngeal carcinomas. Head Neck. 2004;26:953-959.
17. Edney T, Pillevuit O, Soldati D, et al. 158 functional pharyngectomies and pharyngolaryngectomies (1981-2001): complications and results. Schweiz Med Forum. 2004;4(suppl 16):98S-101S.
18. Crampette L, Garrel R, Gardiner Q, et al. Modified subtotal laryngectomy with cricohyoidoepiglottopexy - long term results in 81 patients. Head Neck. 1999;21:95-103.
19. Cabanillas R, Rodrigo JP, Llorente JL, Suarez V, Ortega P, Suarez C. Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2004;26:653-659.
20. Lippert BM, Teymoortash A, Folz BJ, Werner JA. Wound healing after laser treatment of oral and oropharyngeal cancer. Lasers Med Sci. 2003;18:36-42.
21. McMahon J, O'Brian CJ, Pathak I, et al. Influence of condition of surgical margins on local recurrence and disease-specific survival in oral and oropharyngeal cancer. Br J Oral Maxillofac Surg. 2003;41:224-231.
22. Pellanda A, Grosjean P, Leoni S, Mihaescu A, Monnier P, Pasche P. Abrasive esophageal cytology for the oncological follow-up of patients with head and neck cancer. Laryngoscope. 1999;109:1703-1708.
23. Makeieff M, Mercante G, Jouzdani E, et al. Supraglottic hemipharyngolaryngectomy for the treatment of T1 and T2 carcinomas of laryngeal margin and piriform sinus. Head Neck. 2004;26:701-705.
24. Chevalier D, Watelet JP, Darras JA, Piquet JJ. Supraglottic hemilaryngopharyngectomy plus radiation for the treatment of early lateral margin and pyriform sinus carcinoma. Head Neck. 1997;19:1-5.